SS Innovations International, a developer of innovative surgical robotic technologies, has completed a private placement of its common stock which generated approximately $18.6 million in gross proceeds, before deducting offering expenses.
In the offering, the company offered and sold a total of 5,774,839 shares of common stock consisting of:
- an aggregate of 1,300,006 shares of common stock at an average price of $4 per share, or a total of approximately $5.2 million, to Dr Sudhir Srivastava, chairman and CEO ($2 million), Dr Frederic H. Moll, vice-chairman ($2 million), and Tim Adams, a director ($1.197 million); and
- an aggregate of 4,474,833 shares of common stock at $3 per share, or a total of approximately $13.4 million, to existing and new investors, led by Manipal Global Health Services, an existing shareholder.
SS Innovations intends to use the net proceeds from this financing for working capital and other general corporate purposes, including advancing the Company’s global expansion efforts.
In connection with a $2.5 million investment by one of the non-affiliate investors in the Private Placement, SS Innovations will pay a FINRA member firm a cash commission of $175,000 (7 percent of the investment) and issue to such firm five-year warrants to purchase 41,667 shares of common stock at an exercise price of $3.45 per share.
Dr Srivastava says: “The net proceeds from this financing will advance our growth initiatives in India and other existing global markets, while supporting our preparation for entry into the United States and European Union markets.
“We anticipate that the US Food and Drug Administration will complete its review of our 510(k) premarket notification for our SSi Mantra surgical robotic system by mid-2026. We also continue along the pathway towards a European Union CE marking certification for the SSi Mantra, which we believe we can also obtain in 2026.”
Dr Srivastava adds: “Insider participation in this financing reflects our strong confidence in SS Innovations’ future and our commitment to democratizing access to world-class surgical robotic care. We appreciate the continuing support of Manipal Global Health Services, a large existing shareholder, and welcome a respected group of new shareholders in the company.”
